RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 69 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2013 | $216,000 | – | 16,600 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,000,000 | $32,200,000 | 3.11% |
| SV Health Investors, LLC | 888,132 | $4,085,000 | 3.05% |
| Sarissa Capital Management LP | 2,725,000 | $12,535,000 | 2.76% |
| GREAT POINT PARTNERS LLC | 1,346,344 | $6,193,000 | 2.22% |
| Virtus ETF Advisers LLC | 126,869 | $584,000 | 0.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $1,840,000 | 0.40% |
| TFS CAPITAL LLC | 459,546 | $2,114,000 | 0.30% |
| GLOBEFLEX CAPITAL L P | 238,239 | $1,096,000 | 0.29% |
| TURNER INVESTMENTS LLC | 161,100 | $741,000 | 0.20% |
| Birchview Capital, LP | 40,000 | $184,000 | 0.13% |